Search Results

There are 8133724 results for: content related to: Tools to improve clinical trial design in urothelial cancer

  1. You have free access to this content
    Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy

    Cancer

    Volume 119, Issue 16, 15 August 2013, Pages: 3012–3019, Matthew D. Galsky, Erin Moshier, Susan Krege, Chia-Chi Lin, Noah Hahn, Thorsten Ecke, Guru Sonpavde, James Godbold, William K. Oh and Aristotle Bamias

    Version of Record online : 29 MAY 2013, DOI: 10.1002/cncr.28146

  2. You have free access to this content
    Detection of circulating urothelial cancer cells in the blood using the CellSearch System

    Cancer

    Volume 109, Issue 7, April 2007, Pages: 1439–1445, Michio Naoe, Yoshio Ogawa, Jun Morita, Kei Omori, Kumiko Takeshita, Takeshi Shichijyo, Taisuke Okumura, Atsushi Igarashi, Atsushi Yanaihara, Sanju Iwamoto, Takashi Fukagai, Akira Miyazaki and Hideki Yoshida

    Version of Record online : 26 FEB 2007, DOI: 10.1002/cncr.22543

  3. You have free access to this content
    Cytotoxic and DNA-targeted therapy in urothelial cancer: Have we squeezed the lemon enough?

    Cancer

    Volume 121, Issue 2, January 15, 2015, Pages: 179–187, Arjun V. Balar and Matthew I. Milowsky

    Version of Record online : 4 AUG 2014, DOI: 10.1002/cncr.28754

  4. You have free access to this content
    Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer

    Cancer

    Volume 119, Issue 11, 1 June 2013, Pages: 1994–1998, Matthew D. Galsky, Ryan Hendricks, Robert Svatek, Rick Bangs, Jean Hoffman-Censits, Jessica Clement, Robert Dreicer, Elizabeth Guancial, Noah Hahn, Seth P. Lerner, Peter H. O'Donnell, Diane Zipursky Quale, Arlene Siefker-Radtke, William Shipley, Guru Sonpavde, Daniel Vaena, Jacob Vinson and Jonathan Rosenberg

    Version of Record online : 1 MAR 2013, DOI: 10.1002/cncr.27973

  5. You have free access to this content
    Prospective randomized double-blind multicentre phase II study comparing gemcitabine and cisplatin plus sorafenib chemotherapy with gemcitabine and cisplatin plus placebo in locally advanced and/or metastasized urothelial cancer: SUSE (AUO-AB 31/05)

    BJU International

    Volume 113, Issue 3, March 2014, Pages: 429–436, Susanne Krege, Heidrun Rexer, Frank vom Dorp, Patrick de Geeter, Theodor Klotz, Margitte Retz, Axel Heidenreich, Michael Kühn, Joern Kamradt, Susan Feyerabend, Christian Wülfing, Stefan Zastrow, Peter Albers, Oliver Hakenberg, Jan Roigas, Martin Fenner, Hans Heinzer and Mark Schrader

    Version of Record online : 14 FEB 2014, DOI: 10.1111/bju.12437

  6. You have free access to this content
    Overweight in Adolescence Is Related to Increased Risk of Future Urothelial Cancer

    Obesity

    Volume 20, Issue 12, December 2012, Pages: 2445–2450, Adi Leiba, Jeremy D. Kark, Arnon Afek, Zohar Levi, Micha Barchana, Dorit Tzur, Estela Derazne, Asaf Vivante and Ari Shamiss

    Version of Record online : 31 DEC 2012, DOI: 10.1038/oby.2012.83

  7. You have free access to this content
    Relationship between 6- and 9-month progression-free survival and overall survival in patients with metastatic urothelial cancer treated with first-line cisplatin-based chemotherapy

    Cancer

    Volume 119, Issue 16, 15 August 2013, Pages: 3020–3026, Matthew D. Galsky, Susan Krege, Chia-Chi Lin, Noah Hahn, Thorsten Ecke, Erin Moshier, Guru Sonpavde, James Godbold, William K. Oh and Aristotle Bamias

    Version of Record online : 29 MAY 2013, DOI: 10.1002/cncr.28145

  8. You have free access to this content
    Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer

    International Journal of Urology

    Volume 17, Issue 3, March 2010, Pages: 254–258, Takatsugu Okegawa, Kenjiro Hayashi, Hidehiko Hara, Kikuo Nutahara and Eiji Higashihara

    Version of Record online : 8 FEB 2010, DOI: 10.1111/j.1442-2042.2010.02454.x

  9. You have free access to this content
    Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802)

    Cancer

    Volume 112, Issue 12, 15 June 2008, Pages: 2671–2675, Robert Dreicer, Hailun Li, Matthew M. Cooney, George Wilding and Bruce J. Roth

    Version of Record online : 5 MAY 2008, DOI: 10.1002/cncr.23503

  10. You have free access to this content
    Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer

    International Journal of Urology

    Volume 22, Issue 5, May 2015, Pages: 490–494, Satoru Muto, Hideyuki Abe, Takahiro Noguchi, Sho-ichiro Sugiura, Kousuke Kitamura, Shuji Isotani, Hisamitsu Ide, Raizo Yamaguchi, Takao Kamai and Shigeo Horie

    Version of Record online : 28 FEB 2015, DOI: 10.1111/iju.12727

  11. You have free access to this content
    The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2641–2650, Funso Abogunrin, Hugh F. O'Kane, Mark W. Ruddock, Michael Stevenson, Cherith N. Reid, Joe M. O'Sullivan, Neil H. Anderson, Declan O'Rourke, Brian Duggan, John V. Lamont, Ruth E. Boyd, Peter Hamilton, Thiagarajan Nambirajan and Kate E. Williamson

    Version of Record online : 14 SEP 2011, DOI: 10.1002/cncr.26544

  12. You have free access to this content
    Novel agents for muscle-invasive and advanced urothelial cancer

    BJU International

    Volume 101, Issue 8, April 2008, Pages: 937–943, Guru Sonpavde, Robert Ross, Thomas Powles, Christopher J. Sweeney, Noah Hahn, Thomas E. Hutson, Matthew D. Galsky, Seth P. Lerner and Cora N. Sternberg

    Version of Record online : 13 NOV 2007, DOI: 10.1111/j.1464-410X.2007.07326.x

  13. Long-term results with M-VAC for advanced urothelial cancer: high relapse rate and low survival in patients with a complete response

    British Journal of Urology

    Volume 76, Issue 3, September 1995, Pages: 321–324, M. IGAWA, S. URAKAMI, H. SHIINA, T. ISHIBE, H. KADENA and T. USUI

    Version of Record online : 21 NOV 2008, DOI: 10.1111/j.1464-410X.1995.tb07708.x

  14. You have full text access to this Open Access content
    Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: A phase II study of the SUOC group

    Cancer Science

    Volume 102, Issue 6, June 2011, Pages: 1171–1175, Hiroshi Kitamura, Keisuke Taguchi, Yasuharu Kunishima, Masahiro Yanase, Atsushi Takahashi, Masanori Shigyo, Toshiaki Tanaka, Masatoshi Mutoh, Fumimasa Fukuta, Naoya Masumori and Taiji Tsukamoto

    Version of Record online : 14 MAR 2011, DOI: 10.1111/j.1349-7006.2011.01909.x

  15. You have free access to this content
    Synchronous bilateral urothelial cancer in a kidney recipient

    International Journal of Urology

    Volume 18, Issue 12, December 2011, Pages: 847–850, Ryuto Nakazawa, Satetsu Miyano, Hideo Sasaki, Hiroya Kudo, Kenjiro Kimura and Tatsuya Chikaraishi

    Version of Record online : 17 OCT 2011, DOI: 10.1111/j.1442-2042.2011.02854.x

  16. Urothelial cancer and some industry-related chemicals: An evaluation of the epidemiologic literature

    American Journal of Industrial Medicine

    Volume 17, Issue 3, 1990, Pages: 371–391, Gunnar Steineck, Nils Plato, Staffan E. Norell and Christer Hogstedt

    Version of Record online : 19 JAN 2007, DOI: 10.1002/ajim.4700170310

  17. You have free access to this content
    Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy

    International Journal of Urology

    Volume 14, Issue 6, June 2007, Pages: 500–504, Akira Yokomizo, Ken Yamamoto, Naoko Kinukawa, Toshiyuki Tsunoda, Hirofumi Koga and Seiji Naito

    Version of Record online : 8 MAY 2007, DOI: 10.1111/j.1442-2042.2007.01769.x

  18. You have free access to this content
    Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8–10/CD44v10 competitive RT-PCR

    International Journal of Cancer

    Volume 79, Issue 6, 18 December 1998, Pages: 560–564, Hideaki Miyake, Isamu Okamoto, Isao Hara, Kazuo Gohji, Kazuki Yamanaka, Soichi Arakawa, Sadao Kamidono and Hideyuki Saya

    Version of Record online : 12 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19981218)79:6<560::AID-IJC2>3.0.CO;2-X

  19. You have free access to this content
    Chemotherapeutic and targeted biological agents for metastatic bladder cancer: A comprehensive review

    International Journal of Urology

    Volume 21, Issue 7, July 2014, Pages: 630–637, Terence T Sio, Jocelyn Ko, Vinay K Gudena, Nitin Verma and Uzair B Chaudhary

    Version of Record online : 23 JAN 2014, DOI: 10.1111/iju.12407

  20. Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association

    International Journal of Urology

    Volume 23, Issue 3, March 2016, Pages: 224–230, Junichi Inokuchi, Seiji Naito, Hiroyuki Fujimoto, Tomohiko Hara, Mizuaki Sakura, Hiroyuki Nishiyama, Jun Miyazaki, Eiji Kikuchi, Shiro Hinotsu, Takuya Koie, Chikara Ohyama and on behalf of the Cancer Registration Committee of the Japanese Urological Association

    Version of Record online : 14 DEC 2015, DOI: 10.1111/iju.13031